スライド 1 - BioMed Central

Control
0.1μM dasatinib
0.1μM Eto
Dasatinib +
etoposide
With DEAB
Without DEAB
The proportion of
ALDH1-positive
5.25%
3.49%
7.81%
3.29%

Download Report

PowerPoint プレゼンテーション

PowerPoint プレゼンテーション

SpectroDens Features

SpectroDens Features

Lung cancer standard regimens

Lung cancer standard regimens

pep-c - Comtecmed

pep-c - Comtecmed

© Copyright 2024 ExpyDoc